Evidence map›Paper›PMID 42227181›Full record

ArticleJournal of the American Chemical Society2026

Phenoxazines with a Phototransferable

Elizaveta Savicheva, Jasmine Hubrich, Taukeer A Khan, Mariano L Bossi, Vladimir N Belov, Lutz Ackermann, Stefan W Hell

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Elizaveta SavichevaDepartment of NanoBiophotonics, Max Planck Institute for Multidisciplinary Sciences (MPI NAT), Göttingen 37077, Germany.
Jasmine HubrichDepartment of Optical Nanoscopy, Max Planck Institute for Medical Research (MPI MR), Heidelberg 69120, Germany.
Taukeer A KhanDepartment of NanoBiophotonics, Max Planck Institute for Multidisciplinary Sciences (MPI NAT), Göttingen 37077, Germany.
Mariano L BossiDepartment of Optical Nanoscopy, Max Planck Institute for Medical Research (MPI MR), Heidelberg 69120, Germany.ORCID 0000-0001-6755-8074
Vladimir N BelovDepartment of NanoBiophotonics, Max Planck Institute for Multidisciplinary Sciences (MPI NAT), Göttingen 37077, Germany.ORCID 0000-0002-7741-4653
Lutz AckermannInstitut für Organische und Biomolekulare Chemie (IOBC), Georg-August-Universität Göttingen, Göttingen 37077, Germany.ORCID 0000-0001-7034-8772
Stefan W HellDepartment of NanoBiophotonics, Max Planck Institute for Multidisciplinary Sciences (MPI NAT), Göttingen 37077, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Photoactivatable (PA) fluorescent dyes with a reactive group are designated markers used in bioimaging techniques, tracking cellular processes, and observing the nanoscale organization of biological specimens with high spatiotemporal resolution. Conventional (non-PA) phenoxazine dyes are widely used in fluorescence microscopy owing to their high brightness, fluorescence emission in the far-red, and outstanding photostability, which allow their detection down to single molecules. So far, there has been no general synthetic route to PA oxazines with various emission colors and a reactive group. By applying metal-catalyzed C-H activation to symmetric and easily available N

Indexed as

AcrylatesFluorescent DyesOxazinesHumansMicroscopy, FluorescenceMolecular StructurePhotochemical ProcessesAcrylatesFluorescent DyesOxazinesphenoxazine

Identifiers

PMID42227181
PMCPMC13281514

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.